Guerin Mark Patrick

Avg. Two Year Performance

(16%) Avg. Purchase Return
(8%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return30%90%(11%)(15%)(16%)
Purchase Success Rate1 of 31 of 31 of 30 of 30 of 3
Average Sale Return----------
Sale Success Rate----------

Traws Pharma, Inc.

Drugs » Biotechnology

CFO AND COO:

Holdings: 35.98K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--